Literature DB >> 9372933

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.

J M Yingling1, M B Datto, C Wong, J P Frederick, N T Liberati, X F Wang.   

Abstract

Members of the Smad family of proteins are thought to play important roles in transforming growth factor beta (TGF-beta)-mediated signal transduction. In response to TGF-beta, specific Smads become inducibly phosphorylated, form heteromers with Smad4, and undergo nuclear accumulation. In addition, overexpression of specific Smad combinations can mimic the transcriptional effect of TGF-beta on both the plasminogen activator inhibitor 1 (PAI-1) promoter and the reporter construct p3TP-Lux. Although these data suggest a role for Smads in regulating transcription, the precise nuclear function of these heteromeric Smad complexes remains largely unknown. Here we show that in Mv1Lu cells Smad3 and Smad4 form a TGF-beta-induced, phosphorylation-dependent, DNA binding complex that specifically recognizes a bipartite binding site within p3TP-Lux. Furthermore, we demonstrate that Smad4 itself is a DNA binding protein which recognizes the same sequence. Interestingly, mutations which eliminate the Smad DNA binding site do not interfere with either TGF-beta-dependent transcriptional activation or activation by Smad3/Smad4 cooverexpression. In contrast, mutation of adjacent AP1 sites within this context eliminates both TGF-beta-dependent transcriptional activation and activation in response to Smad3/Smad4 cooverexpression. Furthermore, concatemerized AP1 sites, in isolation, are activated by Smad3/Smad4 cooverexpression and, to a certain extent, by TGF-beta. Taken together, these data suggest that the Smad3/Smad4 complex has at least two separable nuclear functions: it forms a rapid, yet transient sequence-specific DNA binding complex, and it potentiates AP1-dependent transcriptional activation.

Mesh:

Substances:

Year:  1997        PMID: 9372933      PMCID: PMC232558          DOI: 10.1128/MCB.17.12.7019

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

Review 3.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

4.  Smad4 and FAST-1 in the assembly of activin-responsive factor.

Authors:  X Chen; E Weisberg; V Fridmacher; M Watanabe; G Naco; M Whitman
Journal:  Nature       Date:  1997-09-04       Impact factor: 49.962

5.  Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.

Authors:  A Hata; R S Lo; D Wotton; G Lagna; J Massagué
Journal:  Nature       Date:  1997-07-03       Impact factor: 49.962

Review 6.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

7.  Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic.

Authors:  J Kim; K Johnson; H J Chen; S Carroll; A Laughon
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

8.  Characterization of functional domains within Smad4/DPC4.

Authors:  M P de Caestecker; P Hemmati; S Larisch-Bloch; R Ajmera; A B Roberts; R J Lechleider
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

9.  TGF beta signals through a heteromeric protein kinase receptor complex.

Authors:  J L Wrana; L Attisano; J Cárcamo; A Zentella; J Doody; M Laiho; X F Wang; J Massagué
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

10.  Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

Authors:  M R Keeton; S A Curriden; A J van Zonneveld; D J Loskutoff
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  62 in total

1.  A function of CBP as a transcriptional co-activator during Dpp signalling.

Authors:  L Waltzer; M Bienz
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  Smads bind directly to the Jun family of AP-1 transcription factors.

Authors:  N T Liberati; M B Datto; J P Frederick; X Shen; C Wong; E M Rougier-Chapman; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.

Authors:  H Kaji; L Canaff; J J Lebrun; D Goltzman; G N Hendy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.

Authors:  B J Irvin; B L Williams; A E Nilson; H O Maynor; R T Abraham
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 6.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

7.  Peptide ligands that use a novel binding site to target both TGF-β receptors.

Authors:  Lingyin Li; Brendan P Orner; Tao Huang; Andrew P Hinck; Laura L Kiessling
Journal:  Mol Biosyst       Date:  2010-10-04

8.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.

Authors:  Eyal Kalo; Yosef Buganim; Keren E Shapira; Hilla Besserglick; Naomi Goldfinger; Lilach Weisz; Perry Stambolsky; Yoav I Henis; Varda Rotter
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

10.  Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.

Authors:  Daizo Koinuma; Shuichi Tsutsumi; Naoko Kamimura; Hirokazu Taniguchi; Keiji Miyazawa; Makoto Sunamura; Takeshi Imamura; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.